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This paper deals with the modelling of genetic mutations, which occur in almost all cells
of a living system. The mutated cells display different stages of cancer progression and
are contrasted by the action of the immune system cells. This investigation can be of
interest in the evolutionary dynamics of cellular systems since the selective pressure on
the mutated cells exerted by the immune system is analyzed. The proposed mathematical
model is developed bymeans of the tools of the kinetic theory of active particles. Numerical
simulations, obtained considering different values of the parameters in the model, show
different emerging behaviors that are typical of the cancer-immune system competition.
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1. Introduction
The last fifty years have witnessed rapid advances in biological sciences, mostly due to the developments of Genetics and
Immunology, starting from the seminal paper [1]. In particular, the completion of the human DNA decoding made possible
– theoretically – to explain several aspects of complex biological phenomena at the molecular scale, and the consequent
refining of the investigation techniques made available a big amount of data and observations. Many scientists suggest
the need for a new approach, where the complexity of a biological system may become understandable in terms of a
small number of underlying principles, by means of suitable simplifications and representations of the phenomena, see
for instance [2].
Physicists and mathematicians have accepted, following the guidelines of the biologists, the challenge to construct
mathematical models able to reproduce emerging behaviors and possibly, as typical of the explorative models, to show
phenomena that are not fully observed experimentally. Different mathematical approaches have been proposed, related to
the different representation scales (molecular, cellular, and tissue scale) at which the biological system is analyzed. Among
others, cellular automata models, population dynamics, population dynamics with internal structures, statistical models,
macroscopic models, each of them developed at a specific observation scales and with specific mathematical tools. The
reader can find additional bibliography in the book [3], in the review papers [4–6].
Various problems in the life sciences have been recently modelled by means of the tools of the mathematical kinetic
theory of active particles, briefly KTAP, that have been settled in a general mathematical framework [7]. KTAP is applied
in this paper at the cellular scale to describe, by mathematical equations, the system classified in cell populations, which
are grouped according to their functional behavior. The term active particles [8] denotes the population entities that are
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identified by their microscopic state, which includes a scalar variable, the activity, related to the functional behavior of the
particles. The state of the overall system is then described by a set of distribution functions over the microscopic state of
the interacting active particles, and the evolution of the system is determined by the microscopic interactions, which are
ruled by a somehow organized behavior or strategy, [9,10]. This approach is coherent to some suggestions of Hartwell el
al. [11]: ‘‘[. . . ] the notion of function or purpose differentiate biology from other natural sciences [. . . ]. What really distinguishes
biology from physics are survival and reproduction, and the concomitant notion of function’’. A further important hint is offered
by Nowak, [12], who suggests to overcome the traditional approach to cancer modelling in terms of growth by looking at
evolution and mutations.
KTAP’s methods have been applied since [13] to model cancer phenomena and cellular dynamics and the competition
between tumor and immune cells as documented in the book [14] as well as in several papers, [15–21].
This paper deals with the modelling of genetic mutations, which result in the onset of tumor cells with different
progression features, thus generating biological heterogeneity phenomena [22,23], contrasted by the action of the immune
system [18,19,24–29]. This investigation can be of interest in the evolutionary dynamics of cellular systems and it focuses
on the evolution of progression and heterogeneity of living systems, and specifically on cancer phenomena and immune
competition: the selective pressure on the mutated cells exerted by the immune system is analyzed, while in the literature,
different types of selective pressure acting on cancer cells are considered, as for instance those exerted by therapies [30], or
by environmental conditions [31]. Unlike other mathematical approaches, by KTAP methods, it is possible to highlight the
heterogeneity, whichmay arise in the evolution of some biological systems (as, for instance, the increasingmalignancy of the
mutated cells). This gives a deeper insight on tumorigenesis adding information on the evolution of phenotypes. The above
cited publications take into account heterogeneity of cell phenotypes and progression, but not mutations that generate new
cell populations. The novelty of this paperwith respect to the existing literature consists in introducing this specific aspect of
mutations and the possibility of modelling pathways to reach the stage of cancer cells, including the transition from normal
to neoplastic cells that, related to Darwinian selection, can have a crucial role in the immune competition.
Mutations at a lower scale, due to a rapid adaptation to the environment, have been first applied in [32] focusing on virus
mutations carried by vertebrates. This paper is based on a mathematical framework defined in [4]. Moreover, paper [33]
shows how mutations play an important role in the evolution of fibrosis disease in the presence of the immune system.
In general, mathematical models can be divided into two main groups: predictive models, that have the ability of
describing the evolution of the system and that involve parameters, which have been well identified by comparisons with
empirical data; explorative models, whose aim consists in investigating the trend of the system corresponding to different
parameters which are left free. The model proposed in this paper is ‘‘explorative’’ rather than ‘‘predictive’’, and its analysis
is mainly concerned with identifying the cellular phenomena that characterize the system evolution, depicting, if possible,
emerging behaviors which cannot be easily derived from the initial conditions.
In detail, the paper is organized in five more sections which follow this introduction. Section 2 introduces a short
phenomenological description of the biological processes we are dealing with. Section 3 deals with a brief description of the
methods of the mathematical kinetic theory of active particles, and develops the mathematical framework as a reference
for the modelling process. Section 4 presents a mathematical model for a system of cells populations, which may shift into
newpopulations of cellswith progressingmutation, contrasted by the immune system. Section 5 dealswith a computational
analysis of the initial value problemgenerated by the application of themodel to real system analysis. Numerical simulations
are related to the increase of the mutation rate of the abnormal cells, and to the increase of the proliferation of the immune
systemcells. Section 6 focuses on the critical analysis of themathematical approach, suggesting possible further refinements,
to be regarded as a research perspective.
2. A phenomenological description
A multicellular organism is constituted of interacting cells that, organized in specialized tissues cooperate to ensure the
life of the organism. The cell functions are controlled by the genes, variable-length sequences of the DNA contained in the
cell nucleus. The complex of the genes rules the life of the whole individual, leading the cells to perform their specific role
in a tissue, limiting the growth of the cell number, forcing them first to reproduce and then to die.
A gene mutation is a permanent change in the DNA sequence that makes up a gene. Gene mutations occur in two ways:
they can be inherited from a parent (hereditary or germline mutations), or acquired during a person’s lifetime (acquired or
somatic mutations). The corruption of a genetic locus (a specific site along the length the DNA string) may occur because of
physical or chemical exogenous agents, or, more usually, because of some mistake during DNA replication in the process of
the cell reproduction (mitosis). Remembering that approximately 1016 mitoses occur during a normal human life span, it
seems likely that every day everyone has to suffer some kind of genome alteration, despite the efficient processes of ‘‘check
and repair’’ of the duplicated DNA, which are typical of the mammalian organisms.
Almost every tumor arises because of random DNA mutations, which corrupt the genes of a cell and alter the genetic
regulatory circuits that control the cell functions. Therefore, normal cells evolve progressively through increasingly
abnormal (dysplastic) states until the neoplasia. The formation of a tumor and its development, the so-called tumor
progression, is a quite complex process that normally spreads over many years (ten or more). Luckily, not every genetic
corruption leads to the genesis of tumor cells: many of them are indifferent to the normal cell life, many others make the
genome of the mutated cell so unstable that the cell dies after a short time.
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The number of geneticmutations that are required to justify tumorigenesis is very high, far beyond the number of genetic
mutations which occur during normal human life. However, sometimes a random DNAmutation may provide a normal cell
with a sort of genomic instability: even if it does not seem to provide an immediate benefit in terms of proliferation and
survival, genomic instability greatly increases the speed of further genetic mutations and makes easier the acquisition of
other characteristics. Even if not easily quantified, the acquired genomic instability should be considered as an ‘‘enabling
characteristic’’ in tumorigenesis. Therefore a cell may incur into a crucial and specific alteration in one of its genes, which
gives it a significant advantage with regard to survival and proliferation, and allows it and its descendent to quickly advance
along the tumor progression. Only a small portion of hundreds of the alterations present in many neoplastic cells’ genomes
actually plays causal roles in the process of tumorigenesis: mutation of a small number of critical control genes seems to be
the way to acquire neoplastic cell phenotype.
Human cancer cells share a set of common characteristics (the so called ‘‘hallmarks of cancer ’’), acquired on the way to
full malignant state [2]:
(i) capability of providing their own growth signals, i.e. autocrine signalling;
(ii) resistance to growth-inhibitory signals;
(iii) capability to proliferate indefinitely;
(iv) capability of angiogenesis;
(v) capability of escaping apoptosis;
(vi) metastatic capability.
Each characteristic, which is reached throughmultistep procedures, may represent a distinct phase in the tumorigenesis.
They are acquired in differentways and times from tumor to tumor (though hallmarks (i) and (ii) are generally reached first),
and even a single genetic mutation may help in reaching more than one characteristic simultaneously. Completion of each
step in tumor progression can be viewed as the successful reaching of one of the above attributes.
Generally, a tumor develops progressively, demonstrating different gradations of abnormality along the way from being
benign to metastatic. A tumor generally arises from the genetic mutation of a single cell (the so-called monoclonal cancer),
and, at the same time, descendant cells with different types of genetic mutations are present; thus the tumor tissue shows
genetic heterogeneity of cells [23]. Between the two extremes of fully normal tissues and highlymalignant tissues lies a broad
spectrum of intermediate appearance, which we read as a statistical distribution of the cells’ progression. The different
gradations of abnormality may well reflect cell populations that are evolving progressively away from normal and toward
greater degrees of aggressive and invasive behavior.
The human body rises several lines of defense to contrast the onset and progression of a tumor: some of them are specific
to the cell lifecycle, as the monitoring of DNA duplication, other defenses are specific to the organization of tissues, as the
protection of stem cells and their genome. Besides those defenses, the human body is protected against infectious agents by
the immune system.
The immune system is a complex of different cells and molecules which provides a strong and effective defense against
pathogenic agents. The cells of the immune system, globally called leukocytes or white blood cells, communicate via cell-
to-cell contact or via chemical signals through specific secreted substances and cooperate in continuously monitoring the
environment, detecting and attacking foreign infectious agents.
The questionwhether the immune system,which is specialized to detect and eliminate foreign agents,may also recognize
as ‘‘foreign’’ tumor cells or more in general mutated cells, which are native to the body, has been a matter of discussions
between biologists. Today, evidence is rapidly accumulating that the immune system contributes to the body multilayered
defenses against tumors. The interested reader may find in [34] a complete and up-to date reference about the biology of
cancer.
3. The underlying mathematical framework
This section deals with the development of a general mathematical framework, which constitutes a paradigm for the
derivation of specific models. This framework is derived following the kinetic theory of active particles [7]. Specifically, in
order to reduce the complexity of the system under consideration, the overall system is divided into different populations
of particles, each of them characterized by a common biological function and constituted by particles with a heterogeneous
microscopic state. If the system is constituted by n populations of interacting particles (called active particles), whose
microscopic state is represented by the scalar variable u ∈ R+ = [0,∞[ (called activity), the evolution of the i-th population,
for i ∈ {1, 2, . . . , n}, is described by the distribution function fi = fi(t, u) : [0, T ] ×R+ → R+ over the state u at the time t .
The evolution of each population is determined by the interactions which occur between particles within the same
or different populations. The considered interactions are both conservative (the microscopic state of the particles is
modified without changing their whole number) and non-conservative (the number of particles is changed as a result of
proliferative/destructive events, including transition of population). Three different types of particles can be distinguished:
candidate, test, and field particles. Candidate particles can acquire, in probability, the state of the test particles after an
interaction with field particles, while test particles may loose their state after interactions.
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Under suitable integrability assumptions on fi, gross averaged quantities can be computed. For instance, the local number
density of particles, belonging to the i-th population at the time t, is computed as follows:
ni(t) =
∫ ∞
0
fi(t, u) du. (1)
The evolution equation of the distribution function fi is obtained by the balance of particles in the elementary volume
[u, u+ du] of the space of the microscopic states. Technical calculations, see [14], yield:
∂t fi(t, u) = Ji[f ](t, u) = Ci[f ](t, u)+ Ti[f ](t, u)+ Ni[f ](t, u), (2)
where the left hand side term models the flow, at the time t , into the elementary volume of the state space of the i-th
population due to transport and interactions, while the terms in the right hand side of Eq. (2) have, for i, j ∈ {1, 2, . . . , n},
the following meaning:
- Ci[f ](t, u) models the flow, at the time t , into the elementary volume of the state space of the i-th population due to
conservative interactions, and it has the following form:
Ci[f ](t, u) =
n−
j=1
ηij
∫ ∞
0
∫ ∞
0
Bij(u∗ → u| u∗, u∗)fi(t, u∗)fj(t, u∗) du∗ du∗ − fi(t, u)
n−
j=1
ηij
∫ ∞
0
fj(t, u∗) du∗, (3)
where ηij, here assumed as constant, is the encounter rate between the candidate particle, with state u∗, of the i-
th population and the field particle, with state u∗, of the j-th population. The term Bij(u∗ → u| u∗, u∗) denotes the
probability density that a candidate particle, with state u∗, of the i-th population ends up into the state u of the test
particle of the same population after the interactionwith the field particle, with state u∗, of the j-th population.Moreover,
it satisfies the following condition:∫ ∞
0
Bij(u∗ → u| u∗, u∗) du = 1, ∀ u∗, u∗ ∈ R+. (4)
- Ti[f ](t, u)models the net flow, at the time t , into the elementary volume of the state space of the i-th population due to
proliferative interactions with transition of population. This term has the following form:
Ti[f ](t, u) =
n−
h=1
n−
k=1
ηhk
∫ ∞
0
∫ ∞
0
µ
i≠h
hk (u∗, u
∗; u)fh(t, u∗)fk(t, u∗) du∗ du∗, (5)
whereµi≠hhk (u∗, u∗; u)models the net proliferation of the candidate particle, with state u∗, of the h-th population and the
field particle, with state u∗, of the k-th population, into the i-th population, due to interactions that occur with rate ηhk.
- Ni[f ](t, u)models the net flow, at the time t , into the elementary volume of the state space of the i-th population due to
proliferative and destructive interactions without transition of population:
Ni[f ](t, u) = fi(t, u)
n−
j=1
ηij
∫ ∞
0
µij(u, u∗)fj(t, u∗) du∗, (6)
where µij(u, u∗)models net flux within the same population due to interactions of the test particle, with state u, of the
i-th population and the field particle, with state u∗, of the j-th population, which occur with rate ηij.
Substituting the previous expressions into Eq. (2), yields:
∂t fi(t, u) =
n−
j=1
ηij
∫ ∞
0
∫ ∞
0
Bij(u∗ → u| u∗, u∗)fi(t, u∗)fj(t, u∗) du∗ du∗ − fi(t, u)
n−
j=1
ηij
∫ ∞
0
fj(t, u∗) du∗
+
n−
h=1
n−
k=1
ηhk
∫ ∞
0
∫ ∞
0
µ
i≠h
hk (u∗, u
∗; u)fh(t, u∗)fk(t, u∗) du∗ du∗
+ fi(t, u)
n−
j=1
ηij
∫ ∞
0
µij(u, u∗)fj(t, u∗) du∗. (7)
The above framework is space homogeneous. The interested reader can find recent developments on the modelling of
space dependent phenomena in [14,35]. Specific models are obtained by a detailed modelling of microscopic interactions
generating well defined expressions of the terms η,B, and µ.
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4. The mathematical model
The derivation of a model means providing, by a suitable phenomenological interpretation, a mathematical description
of the microscopic interactions among the selected populations, which will be transferred into the framework proposed in
Section 3.
The complexity of the biological phenomena, as briefly summarized in Section 2, is hardly depicted through a single
mathematical model. Thus, we need to focus our attention to specific phenomena. In particular, we focus on early stages of
tumorigenesis and its competition with the immune system cells. Moreover, we develop some approximations in order to
reduce complexity, considering the following biological assumptions:
(i) Even if the above defined hallmarks are acquired bymalignant cells in a quite variable order during tumor progression,
we shall assume that some of them are typical of a specific state (e.g. themetastatic competence is typical of neoplastic
cells) while others are common to both pre-neoplastic and neoplastic cells.
(ii) Genetic corruption occurs during the cell’s lifetime and mostly during mitosis in the process of DNA replication. We
shall assume that random DNA corruptions affect, with a small probability, normal cells and mutated (both pre-
neoplastic and neoplastic) cells. The increase of progression corresponds to these random genetic mutations that, due
to a selective evolutionary process, generate more aggressive mutated cells. A crucial genetic modification, leading to
the acquisition of some of the above hallmarks, corresponds to amutation in population, i.e. a change of population.
Obviously, not all mutations give a selective advantage in terms of cell survival and/or reproduction. When the
genetic mutation gives no significative advantage (or even a selective disadvantage), the affected cell is destined
to die, as a result of the competition with the other cells or with the environment. Therefore, since these mutated
cells are ‘‘neutral’’ (they do not play an active part in the system’s evolution), we neglect them and we consider only
advantageous mutations.
(iii) The progression is a ‘‘one-way-only’’ process, i.e. it goes in the direction of even greater genetic mutations.
(iv) The populations of mutated cells show at the same time cells with different levels of progression. We shall refer to
this statistically distributed progression in the environment as heterogeneity of progressing cells.
(v) The immune system is able to recognize and attack themutated cells. At least at early steps of tumorigenesis, mutated
cells display specific antigens on their surfaces; if an immune cell withmatching receptors encounters such amutated
cell, it is able to kill it.
(vi) The mutated cells show the increasing ability to hide themselves from the immune system (immunoselection), and, at
late steps of progression, the ability of immunosubversion, thus inhibiting and poisoning the immune system.
(vii) Cells are considered as homogeneously distributed. The model focuses on the heterogeneity of cell mutations;
therefore, cells’ spatial position does not modify the system evolution, since we focus on DNAmutations and changing
phenotypes in a local environment. For our purpose, interactions are relevant, while the distance of interacting cells
is irrelevant.
(viii) The interactions between cells are normally mediated by complex intercellular mechanisms and multiple cell
interactions may occur, anyhow we simplify this process and we model local interactions only.
4.1. Cell populations and their activity variable
The model is developed assuming that the multicellular system is constituted by four interacting populations of cells
expressing a well-defined ‘‘biological function’’ represented by the variable u, according to a functional partition of the
system [9]. In the case of mutated cells, the function may be related to the acquisition of the previous defined hallmarks
and, in the case of the immune system cells, it may be related to the immune response as a whole.
The model is derived assuming that the system is constituted by the following interacting cell populations:
1. Normal cells. The activity variable u is the differentiation related to the age of the cells. The normal cells, with growing
values of u, are subjected to the standard cell lifecycle. However, a normal cell may undergo amutationwhich gives it a
significant advantage with regard to survival and proliferation, and allows it and its descendant to quickly advance along
the tumor progression. As a consequence of mutation the normal cells may generate cells in a new population that we
call pre-neoplastic cells.
2. Pre-neoplastic cells. Alteration in gene expression and the degeneration and evolution of cells into different levels of
malignancy is called progression. The activity variable u represents the progression. Increasing values of u indicate an
increasing intensity of progression. Pre-neoplastic cells may have amutation andmay generate cells in a new population
that we call neoplastic cells.
3. Neoplastic or Cancer cells. The activity variable u is again the progression. They are characterized by a relatively greater
genetic instability and ability to proliferate with respect to the pre-neoplastic cells. Moreover, these cells are partially
able to escape the monitoring of the immune system.
4. Immune system cells. The activity variable u is a magnitude of the activation and of the response of the immune system
to foreign agents. These cells have the ability to contrast progressing cells, through recognition and destruction. It is
assumed that when an immune system cell encounters a pre-neoplastic or a cancer cell, it is able to recognize and kill it.
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In the sequel, when we refer to cells of Population 2 and 3 as a whole, we call them mutated cells since they are both
originated from mutations of normal cells. The functional partition in four populations, unlike previous models developed
with KTAP methods, see [4], allows to have a more precise and accurate model, and allows a more detailed insight into
heterogeneity and mutation phenomena.
4.2. Assumptions and interactions modelling
Referring to the mathematical framework proposed in Section 3 by Eq. (7) and the previous defined populations, the
derivation of an evolution equation for the distribution functions over the activity of the cells needs the modelling of the
microscopic interactions between individuals of the various populations.
In the sequel, we discuss only interactions which have non trivial outputs, i.e. an effective change (either in the
microscopic state or in the cells’ number) occurs after the interaction. Thus biological phenomena corresponding to
interactions that give trivial outputs are not to be taken into account, as for instance the physiological birth and death
of cells.
Specifically, the following types of interactions are considered:
- conservative interactions, whichmodify themicroscopic state of each interacting cell but not the size of the populations;
- proliferative and destructive interactions, which generate the birth and death of cells due to pair cell interactions;
- population transition, which describes the proliferation of cells in a new population with respect to the mother cell.
The mathematical model is derived under the following mathematical assumptions:
1. The distributions of the cells’ populations is described by the functions f1(t, u) (normal cells), f2(t, u) (pre-neoplastic
cells), f3(t, u) (neoplastic cells), and f4(t, u) (immune cells).
2. The number of normal cells is assumed to be constant, considering that the apoptosis number roughly balances the
mitosis number (homeostasis of the normal system). Then, the distribution f1(t, u) of the normal population cells is
assumed constant in time, namely:
f1(t, u) = f1(0, u) = f10(u), (8)
where f10 is a constant in time distribution. Thus, normal cells that die because of apoptosis or have a transition into
another cell population, are replaced by new normal cells. Moreover, all cell populations are normalized with respect to
the local number density of the first population:
n10 =
∫ ∞
0
f10(u) du = 1, (9)
which, due to the normalization, is equal to the unity. The normalized densities for the other populations i = 2, 3, 4
writes:
ni(t) =
∫ ∞
0
fi(t, u) du. (10)
3. The system of cells is assumed to be homogeneously distributed in space. According to a mean field approximation,
the encounter rate is assumed to be constant for all interacting pairs; with rescale of time, we set ηij = 1 for all
i, j ∈ {1, 2, 3, 4}.
4. The termBij related to the transition probability density is assumed to be defined by a delta Dirac function (deterministic
output of a pair interaction) depending on the microscopic state of the interacting pairs:
Bij(u∗ → u| u∗, u∗) = δ(u−mij(u∗, u∗)). (11)
5. Proliferation and destruction terms are considered as net ones.
Under the above assumptions, the next step is the modelling of each type of interactions.
• Conservative Interactions.
It is assumed that mutated cells are the only cells subject to conservative interactions, therefore C1(t, u) = C4(t, u) = 0.
The conservative terms C2(t, u) and C3(t, u) are derived under the assumptions that mutated cells of populations 2 and 3
have a tendency to increase their microscopic state with a certain rate, regulated by the interactions with the cells of the
first population which act as a counter clock since they are assumed to be constant in time. Bearing in mind the biological
assumptions reported at the beginning of this section, this evolution toward higher level of progression is called self-
progression. Moreover, it is assumed that the self-progression of neoplastic cells is greater than the self-progression of
a pre-neoplastic cells. Accordingly to Eq. (11), we define:
mij(u∗, u∗) =
u∗ + εαE if j = 1 and i = 2,
u∗ + αE if j = 1 and i = 3,
u∗ otherwise,
(12)
2368 C. Bianca, M. Delitala / Computers and Mathematics with Applications 61 (2011) 2362–2375
where αE is a positive parameter related to the progression rate toward progressing states of mutated cells of the third
population, while ε < 1 is a scale parameter, which takes into account theweaker progression rate of the second population
with respect to the third one. Straightforward calculations give the following non-zero conservative terms:
C2[f ](t, u) = f2(t, u− ϵαE)− f2(t, u), (13)
C3[f ](t, u) = f3(t, u− αE)− f3(t, u). (14)
• Non-Conservative Interactions without Transition of Population.
Proliferation of cells. It is assumed that mutated cells may proliferate (without transition of population) when they
encounter the normal cells. This corresponds to the fact that cells, as all living objects, need feeding to survive and that
a healthy tissue in the cell micro environment has a feeding ability. In particular, the proliferation rate of a neoplastic cell
is greater than the proliferation rate of a pre-neoplastic cell. Indeed, the ability of retrieving nutriments may be related to
the genetic properties and the aggressiveness of the cell, as for instance the ‘‘Epithelial to Mesenchymal Transition’’, [36].
Accordingly to the mechanisms of the immune response, the proliferation of immune cells occurs only if an immune cell
has encountered a mutated cell. Accordingly, we define:
µij(u, u∗) =

εβA if j = 1 and i = 2,
βA if j = 1 and i = 3,
βI if j ∈ {2, 3} and i = 4,
0 otherwise,
(15)
whereβA is a positive parameter corresponding to themaximumproliferation rate of a progressing cell,βI is the proliferation
term of the immune cells, and ε is the scale parameter. The non-zero proliferation terms thus read:
P2[f ](t, u) = εβAf2(t, u), (16)
P3[f ](t, u) = βAf3(t, u), (17)
P4[f ](t, u) = βI f4(t, u)(n2(t)+ n3(t)), (18)
where n2 and n3 are the local density of the populations 2 and 3, respectively, see Eq. (10).
Destruction of cells. The action of immune system cells may lead to the destruction of mutated cells which can be regarded
as the immune surveillance of mutation progression. Neoplastic cells are destroyed by immune cells with less magnitude of
the pre-neoplastic cells.
Neoplastic cells with a high level of progression have the ability to inhibit or destroy immune cells (immune suppression
or immune-subversion). We assume a destruction of the immune cells by neoplastic cells, since inhibited immune cells do
not play a relevant role in the competition and may be equivalently assumed as eliminated. Accordingly, we define:
µij(u, u∗) =

−δA if j = 4 and i = 2,
−εδA if j = 4 and i = 3,
−δSu∗ if j = 3 and i = 4,
0 otherwise,
(19)
where δA is a positive parameter which characterizes the destruction ability of the immune cells, δS is a positive parameter
which characterizes the destruction of the immune cells. Thus, the non-zero destructive terms read:
D2[f ](t, u) = −δAf2(t, u)n4(t), (20)
D3[f ](t, u) = −εδAf3(t, u)n4(t), (21)
D4[f ](t, u) = −δS f4(t, u)
∫ ∞
0
u∗f3(t, u∗), (22)
where n4(t), according to Eq. (10), is the local density of the immune system cells.
• Proliferative Interactions with Transition of Population.
It is assumed that proliferative interactions with transition of population may occur and, after the interaction, a new
cell of the new population appears. In particular, it is assumed that normal cells can mutate and become pre-neoplastic
cells. In turn, the cells can further mutate and become neoplastic cells. Moreover, the microscopic state of the candidate
particles does not change during the transition. The time rate is regulated by interactions with cells of the first population.
Accordingly, we define:
µihk(u∗, u
∗; u) =

γAδ(u− u∗) if h ∈ {1, 2}, k = 1, and i = h+ 1
0 otherwise, (23)
where γA is the jump rate of the population. Thus, the non-zero terms read:
T2[f ](t, u) = γAf1(t, u), (24)
T3[f ](t, u) = γAf2(t, u). (25)
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Table 1
Populations, biological phenomena, and related parameters.
Cell populations Biological phenomenon Parameter
Normal cells Mutation γA
Pre-neoplastic cells
Self-progression εαE
Proliferation εβA
Mutation γA
Neoplastic cells
Self-progression αE
Proliferation βA
Immune subversion δS
Immune system cells
Proliferation βI
Destruction of pre-neoplastic cells −δA
Destruction of neoplastic cells −εδA
4.3. The equations of the model
Replacing the previous terms into Eq. (7), and recalling that the normalization is such that n1(t) = n10 = 1, yields:
∂t f1 = 0,
∂t f2 =

εβA − δA
∫ ∞
0
f4(t, u∗)du∗ − γA − 1

f2(t, u)+ γAf1(t, u)+ f2(t, u− ϵαE),
∂t f3 =

βA − εδA
∫ ∞
0
f4(t, u∗)du∗ − 1

f3(t, u)+ γAf2(t, u)+ f3(t, u− αE),
∂t f4 =

βI
∫ ∞
0
f2(t, u∗)du∗ + βI
∫ ∞
0
f3(t, u∗)du∗ − δS
∫ ∞
0
u∗f3(t, u∗)du∗

f4(t, u).
(26)
The above model is nonlinear, with quadratic type nonlinearity and it is characterized by 7 phenomenological
parameters: the α parameters are related to mass conservative encounters, the β , δ and γ parameters are related to
proliferating/destructive encounters, and ε is a scale parameter. All parameters are positive quantities (eventually equal
to zero). Practical values of these parameters are small with respect to unity.
Particularly important is the fact that the parameters characterizing the model have a well defined biological meaning.
Therefore, the computational analysis can be technically addressed to analyze how different values of the biological
functions may be inserted into the model to describe phenomena of interest in biological sciences.
The Table 1 summarizes the cells’ populations, the biological phenomena taken into account and the related
mathematical parameters concerning the model.
The evolution equations for the density ni(t), for i ∈ {1, 2, 3, 4}, are obtained from Eqs. (26) by integration on R+:
∂tn1(t) = 0,
∂tn2(t) = (εβA − δAn4(t)− γA)n2(t)+ γA +
∫ 0
−ϵαE
f2(t, u) du,
∂tn3(t) = (βA − εδAn4(t))n3(t)+ γAn2(t)+
∫ 0
−αE
f3(t, u) du,
∂tn4(t) = (βIn2(t)+ βIn3(t)− δSa3(t))n4(t).
(27)
This system is not in a closed form, since the distribution functions fi(t, u), for i ∈ {1, 2, 3, 4}, are unknown.
5. Simulations and analysis of the model
Simulations can be obtained by solving the mathematical problem stated by linking the Eqs. (26) to suitable initial
conditions. The statement of the initial value problem can be formally written as follows:
∂t f(t, u) = J[f ](t, u),
f(t = 0, u) = f0(u), (28)
where f = (f1, f2, f3, f4) and J represents the right hand side terms of the system of Eq. (26). The initial condition
f0 = (f1 0, f2 0, f3 0, f4 0) is such that, due to normalization, all distribution functions are divided by the number of cells in
the first population that is assumed to be constant in time:
f1 0 = f1 0(u), n1 0 = 1, (29)
while f2 0 = f3 0 = 0. The initial distribution of immune system cells, f4 0, is different from zero corresponding to the sentinel
value of the immune system.
2370 C. Bianca, M. Delitala / Computers and Mathematics with Applications 61 (2011) 2362–2375
We are interested in studying both the time evolution of the number densities ni, with i = 1, 2, 3, 4, which indicates
cells in a certain population, and the time evolution of the distribution functions fi, with i = 1, 2, 3, 4, which indicates the
progression within each functional subsystem. However (27) is not closed and it has to be integrated jointly with (26).
The initial value problem for a class similar to (26) has been studied in [14], where estimates on the system of the number
densities have been used to compute bounds on the system of the distribution functions so that a local existence theorem
has been extended, in some particular cases, to large times.
This topic is not treated here, where the mathematical problems induce additional difficulties related to the larger
number of equations, while this paper is devoted to simulations to investigate the predictive ability of the model.
Computations are obtained exploiting the same methods of [14], namely by collocation and interpolation functions of
the distribution function, so that the problem for a system of integro–differential equations is approximated by a problem
for a system of ordinary differential equations. Sinc functions [37,38] can be used for interpolation in assuming the natural
trend to zero at infinity.
Simulations are addressed to show the onset of genetic mutated cells, the development of heterogeneity, and the
competition amongmutated cells and cells of the immune system. In particular, as objectives of the computational analysis,
we focus on the following two aspects, among various conceivable ones:
- The sensitivity analysis of the rate of mutation γA.
- The sensitivity analysis of the immune system activation βI .
In view of this, we assume that six of the seven parameters of themodel are fixed, while one of them, the free parameter,
spans from zero to higher values; for the first objective, we consider γA as the free parameter and for the second objective
we choose βI as the free parameter. Simulations should visualize how increasing values of the free parameter modify the
overall evolution of the system, with special attention to progression and heterogeneity phenomena.
Each simulation is performed choosing a non-zero initial condition only for f1(0, u) and f4(0, u), which is a choice
coherent to a physiological state, where only normal cells and immune system cells are initially present.
The common parameters proposed for all the set of simulations are αE = 0.5, βA = 0.2, δA = 0.3, δS = 0.01, ε = 0.1,
corresponding to: a not negligible effect of the progression (αE), a low proliferation of the mutated cells (βA), a low level of
immune subversion (δA), a not too aggressive response of the immune system (δS).
The scale parameter (ε) is related to the difference of behaviors between neoplastic cells and pre-neoplastic cells. The
magnitude of the parameters βI and γA is specified in the following subsections.
5.1. Sensitivity analysis of the mutation rate γA
As a first step we consider the onset of mutated cells and their competition with the immune system cells for different
values of the mutation rate γA. Specifically, fixing the parameters of the model as indicated above, we set βI = 0.3, which
corresponds to a weak immune system cell proliferation, and let γA vary. It is expected that increasing values of γA generate
increasing manifestation of progression and heterogeneity phenomena.
For low mutation rate (γA = 0.11), see left panel of Fig. 1, the number density of neoplastic cells is increased less than the
number of the pre-neoplastic. Indeed, it is assumed that neoplastic cells have a greater rate of progression with respect to
the pre-neoplastic ones but their number and consequently their proliferation depends on how many pre-neoplastic cells
effect the transition of population. In the right panel of Fig. 1, we show the distribution function of the populations 2 and 3
at different instants of time. The role of the conservative interactions that shift the populations 2 and 3 toward increasing
values of progression is very evident.
If we stretch out the time simulation, a critical change in the behavior of the competition occurs, and it is possible to
identify two times tc2 and t
c
3 after which the number of pre-neoplastic and neoplastic cells respectively starts to decrease,
see the left panel of Fig. 3, and Fig. 2 for their distribution functions, until the control and the partial depletion.
Increasing values of γA do not change the asymptotic (in time) scenario since the immune system is still able to react and
proliferate in response to mutated cells. The main difference is that the effect of the mutations with population transition is
greater, see Fig. 4 (with respect to the right panel of Fig. 1), and the critical time tc4 necessary for the immune system cells
to be able to contrast neoplastic cells is greater than in the case of low values of γA (see Fig. 3). Of course this time depends
not only on the specific choice of all parameters but also on the initial conditions.
The previous results suggest that when the rate of mutation γA increases, the time tc2 , t
c
3 from which the immune system
cells start killing themutated cells is a decreasing function of γA. Fig. 5 is realized considering five different rates of mutation
0.11, 0.22, 0.40, 0.65, 0.9. As shown, these simulations support our conjecture both for pre-neoplastic and neoplastic cells.
5.2. Sensitivity analysis of the proliferation rate βI
In this subsection we vary the rate of proliferation βI of the cells of the immune system. The parameters are chosen such
that the proliferation of the mutated cells (βA) and the effects of the self-progression (αE) are not negligible and the rate
of mutation γA is at an intermediate level. Specifically, fixing the parameters as mentioned in the previous section, we set
γA = 0.4 and we vary βI .
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Fig. 1. The evolution in the time interval [0, 8] of the densities of pre-neoplastic cells (dotted line), neoplastic cells (continuous line) for γA = 0.11 (left
panel). Distribution functions, for γA = 0.11, of the pre-neoplastic (dotted line) and the neoplastic cells (continuous line) at different times (right panel).
Fig. 2. Distribution functions of the mutated cells for longer times (γA = 0.11). Pre-neoplastic cells (left panel) and neoplastic cells (right panel).
Fig. 3. Time evolution of the densities of pre-neoplastic cells (dotted line) and neoplastic cells (continuous line) in the time interval [0, 20] for γA = 0.11
(left panel) and for γA = 0.4 (right panel).
It is expected that increasing values of βI produce an increasing activation of the immune system and consequently a
more efficient destruction of the mutated cells in time.
If the immune system cells do not proliferate (βI = 0), while mutated cells are able to proliferate, the number of pre-
neoplastic cells increase in time slowly, while neoplastic cells proliferate indefinitely (see the left panel of Fig. 6). The
immune system cells are unable to proliferate, thus the competition with mutated cells results in a reduction of the
immune system cells (right panel of Fig. 6). This is the only case in which the immune system cells decay, asymptotically
in time, to zero. The model, in this case, reproduces the progressive evolution of the mutated cells towards higher levels of
mutation.
Letting an intermediate proliferation value of the immune system cells (βI = 0.55), the competitionwith themutated cells is
evident. Indeed, as shown in the left panel of Fig. 7, the immune system cells are able to reduce the number of pre-neoplastic
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Fig. 4. Distribution functions of the pre-neoplastic cells (left panel) and the neoplastic cells (right panel) for γA = 0.9 at different times.
Fig. 5. Rate of mutation versus the time tc2 and t
c
3 from which the mutated cells, respectively pre-neoplastic (circle dot) and neoplastic (square dot) cells,
start decreasing.
Fig. 6. Evolution in time of the densities of pre-neoplastic cells (dotted line) and neoplastic cells (continuous line) in the left panel, and immune system
cells in the right panel, in the time interval [0, 8] for βI = 0.
cells after a time tc2 , while the number of neoplastic cells starts to decrease after a greater time t
c
3 > t
c
2 . Nevertheless the
immune system cells, which keep growing in time, asymptotically are able to control and partially deplete mutated cells.
Increasing the value of βI leads to a reduction in the critical times tc2 and t
c
3 but, as expected, the asymptotic scenario is
unchanged, see Fig. 7. Moreover, immune system cells contrast more efficiently neoplastic cells with a low level of mutation
u, as shown in Fig. 8, where the distribution functions at different times for two values of the activation rate βI are reported.
The results of the simulations are summarized in the Table 2.
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Fig. 7. Time evolution of the densities of pre-neoplastic cells (dotted line), neoplastic cells (continuous line) in the time interval [0, 8] for βI = 0.55 (left
panel) and for βI = 0.85 (right panel).
Fig. 8. Distribution function of the neoplastic cells at different times for βI = 0.55 (left panel) and for βI = 0.85 (right panel).
Table 2
Biological phenomena in the time interval [0, 20] for the case γA as free parameter and in the time
interval [0, 8] for the case βI as free parameter.
Fixed parameters Free parameters Biological results
γA = 0.01
Onset of mutated cells
Immune system cells low activation
ε = 0.1 Mutated cells destruction (slowly in time)
βA = 0.2
γA = 0.4
Prevalence of neoplastic cells
δA = 0.3 Immune system cells activation
βI = 0.3 Mutated cells destruction (quickly in time)
δS = 0.01
γA = 0.9
High heterogeneity of mutated cells
αE = 0.5 Immune system cells high activation
More efficient (in time) destruction of mutated cells
βI = 0
Immune system cells inhibition and immunosuppression
Mutated cells evolution in time
ε = 0.1
βA = 0.2
βI = 0.55
Non-negligible immune cells proliferation
δA = 0.3 Pre–neoplastic cells destruction
γA = 0.4 Neoplastic cells weak destruction
δS = 0.01 βI = 0.85 Immune system cells high proliferationαE = 0.5 Efficient destruction of mutated cells
2374 C. Bianca, M. Delitala / Computers and Mathematics with Applications 61 (2011) 2362–2375
6. Critical analysis and perspectives
A mathematical model has been proposed to describe the onset of mutated cells and their progression towards higher
values of mutations, contrasted by the immune system cells, when these cells have the ability to recognize and kill them. A
mathematical structure has been derived according to the methods of the mathematical kinetic theory of active particles,
and, subsequently, a specificmodel has beenderived on the basis of a detailedmathematical description of interactions at the
cellular scale. Simulations have shown how this model is able to predict interesting phenomena concerning heterogeneity
and progression of themutated cells. The validity of themodel is strictly related to the reproducibility of emerging behaviors.
Further investigations may be developed on the role of the immune system. Our assumption is that the immune system,
both with innate and adaptive response, can recognize and kill mutated cells. However, cancer cells are somehow invisible
to the immune system (tumor escape) attack by the selection of non-immunogenic tumor cells (tumor cells which are
tolerated by the immune system, a process called immunoselection) or by the active suppression of the immune response,
the immunosubversion (this phenomenon is simulated in our model by the parameter δS).
Immune system cells are able to perform complex tasks such as learning, acquiring the capability of distinguishing
betweenhost entities (self) and foreign or infected entities (non-self), and evolving in time to achieve better results, retaining
memory of previous encounters with foreign agents for a quicker response in case of re-infection and constantly updating
their reactive potential.
The specificity of the mechanism receptor-antigen is quite efficient and allows a strong defense against a very large
spectrum of possible infectious agents. The capability to detect an infectious agent is called the expressed repertoire, which is
continuously updated by signals specific to the receptors of each lymphocyte: only those,which receive the survival signal by
their environment survive, while the others are selected for apoptosis and are replaced by new lymphocytes with different
receptors. This complex phenomenon can be viewed as an evolutionary dynamic leading to a learning of the immune system.
A further development, from a both mathematical and methodological point of view, can be developed by using the
structures proposed in Section 3 to the molecular scale of representation (scale of genes, [39]). Specifically, the molecular
scale refers to the evolution of a cell regulated by its genes. The output of the dynamics at the molecular scale determines
themain biological functions of the cell. The aim is amultiscale description of the genetic instability, and the derivation, from
genes expression, of the cellular functions. It is a challenging research perspective, where some interesting recent results
have been given, among others [40–42], however this topic still needs to be developed. The link between the molecular and
the cellular scale allows to derive the time evolution of models at the tissue scale obtained by asymptotic methods such as
those used in [43] to derive the celebrated Keller–Segel model.
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